
Opinion|Videos|January 13, 2025
Main Conference Takeaways Regarding cGVHD Management
Author(s)Sergio A. Giralt, MD
Sergio A. Giralt, MD, discusses the key results from recent chronic graft-vs-host disease (cGVHD) research presented at ASH 2024 and how these findings will influence his clinical practice. He also shares his main takeaways on evolving strategies for cGVHD management.
Advertisement
Video content above is prompted by the following:
- What were the key results seen in this abstract and will they carry over to your clinical practice?
- What were your main takeaways with regard to chronic graft-vs-host disease management from ASH 2024?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Investigating the Role of Gut Microbiota in IPF
2
Cost, Access Barriers Limit Women’s Use of Heart Monitors: Lindsey Valenzuela, PharmD
3
GLP-1s Support Weight Loss, Symptom Relief in Psoriasis, Hidradenitis Suppurativa
4
Frequent Dining Out Linked to Higher Colorectal Cancer Risk
5